Conte P F, Alama A, Di Marco E, Canavese G, Rosso R, Nicolin A
Basic Appl Histochem. 1986;30(2):227-31.
Thirty-six patients with locally advanced breast cancer received diethylstilbestrol (1 mg/die) for 3 days followed by FAC (5 Fu 600 mg/m2, adriamycin 50 mg/m2, cytoxan 600 mg/m2) on day 4, q. 21 days. After three cycles, responsive patients were submitted to surgery. Tumor kinetic parameters were evaluated by TLI and PDP-LI in 22 patients on serial tumor biopsies at diagnosis (TO), after DES (T1), 24 hrs after the first FAC (T2) and at the time of radical surgery (T3). An estrogenic recruitment was evident by TLI in 9/22 tumors and by PDP-LI in 16/22 patients. Our results demonstrate that diethylstilbestrol can induce a kinetic recruitment of breast cancer cells independently from their ER content and that chemotherapy is able to stop cell proliferation.
36例局部晚期乳腺癌患者接受己烯雌酚(1毫克/日)治疗3天,随后在第4天接受FAC方案(氟尿嘧啶600毫克/平方米、阿霉素50毫克/平方米、环磷酰胺600毫克/平方米),每21天重复一次。三个周期后,反应性患者接受手术。通过肿瘤标记指数(TLI)和增殖细胞核抗原标记指数(PDP-LI)对22例患者在诊断时(T0)、己烯雌酚治疗后(T1)、首次FAC治疗后24小时(T2)以及根治性手术时(T3)的系列肿瘤活检进行肿瘤动力学参数评估。通过TLI在9/22的肿瘤中以及通过PDP-LI在16/22的患者中发现雌激素募集现象明显。我们的结果表明,己烯雌酚能够独立于乳腺癌细胞的雌激素受体含量诱导其动力学募集,并且化疗能够阻止细胞增殖。